Regeneron Pharmaceuticals, Inc 10-K for FY2019
Regeneron Pharmaceuticals, Inc. (REGN)
10-K
2020-02-07
For: 2019-12-31
View Original
Added on
April 08, 2026
About this 10-K
Regeneron Pharmaceuticals, Inc filed this 10-K on February 7, 2020, covering the fiscal year ended December 31, 2019 (FY2019).
Headline figures
Fiscal year ended December 31, 2019, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $7.86B
- up 17.2% from $6.71B a year earlier
- Net income
- $2.12B
- down 13.4% from net income of $2.44B a year earlier
- Diluted EPS
- $18.46
- down 13.3% from $21.29 a year earlier